rs2295179

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_015192.4(PLCB1):​c.1167+16G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.651 in 1,611,096 control chromosomes in the GnomAD database, including 347,666 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.58 ( 26889 hom., cov: 32)
Exomes 𝑓: 0.66 ( 320777 hom. )

Consequence

PLCB1
NM_015192.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.0480

Publications

17 publications found
Variant links:
Genes affected
PLCB1 (HGNC:15917): (phospholipase C beta 1) The protein encoded by this gene catalyzes the formation of inositol 1,4,5-trisphosphate and diacylglycerol from phosphatidylinositol 4,5-bisphosphate. This reaction uses calcium as a cofactor and plays an important role in the intracellular transduction of many extracellular signals. This gene is activated by two G-protein alpha subunits, alpha-q and alpha-11. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
PLCB1 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 12
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 20-8697799-G-A is Benign according to our data. Variant chr20-8697799-G-A is described in ClinVar as [Benign]. Clinvar id is 260593.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.686 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLCB1NM_015192.4 linkc.1167+16G>A intron_variant Intron 11 of 31 ENST00000338037.11 NP_056007.1 Q9NQ66-1
PLCB1NM_182734.3 linkc.1167+16G>A intron_variant Intron 11 of 32 NP_877398.1 Q9NQ66-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLCB1ENST00000338037.11 linkc.1167+16G>A intron_variant Intron 11 of 31 1 NM_015192.4 ENSP00000338185.6 Q9NQ66-1

Frequencies

GnomAD3 genomes
AF:
0.578
AC:
87783
AN:
151884
Hom.:
26886
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.370
Gnomad AMI
AF:
0.680
Gnomad AMR
AF:
0.514
Gnomad ASJ
AF:
0.710
Gnomad EAS
AF:
0.576
Gnomad SAS
AF:
0.706
Gnomad FIN
AF:
0.700
Gnomad MID
AF:
0.649
Gnomad NFE
AF:
0.682
Gnomad OTH
AF:
0.608
GnomAD2 exomes
AF:
0.621
AC:
155471
AN:
250230
AF XY:
0.638
show subpopulations
Gnomad AFR exome
AF:
0.355
Gnomad AMR exome
AF:
0.408
Gnomad ASJ exome
AF:
0.731
Gnomad EAS exome
AF:
0.586
Gnomad FIN exome
AF:
0.697
Gnomad NFE exome
AF:
0.681
Gnomad OTH exome
AF:
0.645
GnomAD4 exome
AF:
0.659
AC:
961615
AN:
1459094
Hom.:
320777
Cov.:
31
AF XY:
0.663
AC XY:
480965
AN XY:
725876
show subpopulations
African (AFR)
AF:
0.354
AC:
11818
AN:
33402
American (AMR)
AF:
0.415
AC:
18550
AN:
44646
Ashkenazi Jewish (ASJ)
AF:
0.725
AC:
18925
AN:
26088
East Asian (EAS)
AF:
0.561
AC:
22257
AN:
39642
South Asian (SAS)
AF:
0.707
AC:
60848
AN:
86054
European-Finnish (FIN)
AF:
0.691
AC:
36857
AN:
53362
Middle Eastern (MID)
AF:
0.699
AC:
4017
AN:
5746
European-Non Finnish (NFE)
AF:
0.675
AC:
749249
AN:
1109866
Other (OTH)
AF:
0.648
AC:
39094
AN:
60288
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
14381
28762
43143
57524
71905
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19118
38236
57354
76472
95590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.578
AC:
87800
AN:
152002
Hom.:
26889
Cov.:
32
AF XY:
0.581
AC XY:
43197
AN XY:
74288
show subpopulations
African (AFR)
AF:
0.369
AC:
15303
AN:
41452
American (AMR)
AF:
0.513
AC:
7838
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.710
AC:
2461
AN:
3466
East Asian (EAS)
AF:
0.576
AC:
2969
AN:
5154
South Asian (SAS)
AF:
0.706
AC:
3398
AN:
4814
European-Finnish (FIN)
AF:
0.700
AC:
7398
AN:
10568
Middle Eastern (MID)
AF:
0.650
AC:
191
AN:
294
European-Non Finnish (NFE)
AF:
0.682
AC:
46335
AN:
67970
Other (OTH)
AF:
0.611
AC:
1288
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1761
3522
5282
7043
8804
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
746
1492
2238
2984
3730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.648
Hom.:
141253
Bravo
AF:
0.550
Asia WGS
AF:
0.622
AC:
2164
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 12 Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 09, 2014
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 75% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 70. Only high quality variants are reported. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 04, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
5.7
DANN
Benign
0.41
PhyloP100
-0.048
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2295179; hg19: chr20-8678446; COSMIC: COSV62053454; API